| News

MyCamper is a European growth champion

12.03.2021

The Financial Times has included the Basel-based firm MyCamper in its list of the 1,000 fastest-growing startups in Europe. MyCamper acts as a broker for owners of motorhomes and campervans seeking to rent out their vehicles to tourists and vacationers. The company took 53rd place in the rankings.

The team of MyCamper is happy about the success (img: MyCamper)

In March, the Financial Times once again published its list of the 1,000 fastest-growing startups in Europe. MyCamper was the sole Swiss startup to make the top 100, taking 53rd place in the process.

MyCamper brings together owners of motorhomes and campervans with vacationers. The startup organizes vehicle rentals and takes care of insurance documentation and cleaning.

In order to be included in the Financial Times list, companies have to have recorded at least 35.5 percent growth in yearly sales between 2016 and 2019. For MyCamper, the annual growth rate was even as high as 171.5 percent, according to information from the newspaper. In 2019, the Basel-based company generated sales of approximately 3.06 million euros.

MyCamper was founded in 2015 and now employees a total of 17 full-time staff at its headquarters in Basel. In addition, there are two employees based in Stockholm, Sweden, and six who work out of Bosnia-Herzegovina.

For the company, the news that it had made the Financial Times rankings was “an emotional mega-booster, above all in terms of internal motivation”, explains MyCamper CEO Michele Matt in an interview with the newspaper “Handelszeitung”. He also commented that while his company experience a more restrained start to the new year, since February “the bookings have been coming in thick and fast!”. Camping has enjoyed a surge of popularity during the pandemic.

Alongside MyCamper, five other Swiss startups made the list of the best 1,000 firms. These are Frontify from St.Gallen (162nd place), eSMART Technologies based in Renens in the canton of Vaud (247th place), Catalyx (643rd place) and lemonads (989th place) – both from Geneva – in addition to the Aizo Group based in Schlieren in the canton of Zurich (991st place).

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
TargImmune raises nearly 18 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

TargImmune raises nearly 18 million Swiss francs

The Basel-based biotechnology firm TargImmune has raised 17.7 million Swiss francs as part of a financing round. It now intends...

Read More
KetoSwiss launches first product in the USA
Basel Area Business & Innovation, Innovation, Invest

KetoSwiss launches first product in the USA

The Basel-based biotech startup KetoSwiss develops innovative therapies for neurological disorders. Following a successful capital increase, the company now has...

Read More
For Swiss startups, China might be closer than it seems
Basel Area Business & Innovation, Invest

For Swiss startups, China might be closer than it seems

China wants to strengthen domestic demand and be less dependent on imports. This policy has huge implications for the life...

Read More
Basel Area treads unique path
Basel Area Business & Innovation, Innovation, Invest

Basel Area treads unique path

Basel Area is responsible for both location and innovation promotion. This approach, which is unique across Switzerland, is very successful...

Read More
Alentis secures 67 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Alentis secures 67 million US dollars

The Basel-based biotechnology company Alentis Therapeutics has secured 67 million US dollars in a series B funding round. The funds...

Read More
1 2 3 46

Do you have a question? We'd like to hear from you.